Home > Analytics > ANUH PHARMA

ANUH PHARMA
Intrinsic Value | Fundamental Analysis

BOM : 506260     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Apr 16,2024
Price(EOD): ₹ 240.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,202.90 Cr
Value of ₹ 1 Lac invested in ANUH PHARMA
on Apr 16,2019 (price: ₹ 66.93)

₹ 1 L

₹ 3.59 L

1W : 13.4% 1M : 9.1% 1Y : 201.6%
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results
ANUH PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
ANUH PHARMA 13.4% 9.1% 201.6%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

FUNDAMENTAL ANALYSIS OF ANUH PHARMA

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF ANUH PHARMA

 
Valuation Score
[As on : Apr 16,2024 ]

Ratio Standalone
P/E
P/B
P/S
22.15
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 54.32 Cr
[Latest Qtr - Dec2023 - Standalone Results ]

4.99
P/B Calculated based on Book Value of Rs 241.22 Cr
[Latest Year - Mar2023 - Standalone Results ]

1.88
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2023 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 14% undervalued companies ! Discover More →

FAIR VALUE OF ANUH PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
87%
41%
39%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF ANUH PHARMA



ANUH PHARMA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF ANUH PHARMA

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0
0.01
0.07
0.03
-
-
-
-
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF ANUH PHARMA

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF ANUH PHARMA

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
15.09%
33.59%
41.57%
38.14%
24.05%
93.03%
109.48%
105.35%
QtrlyTrend
8
Latest Qtr: Dec2023
Quarterly Result Analysis →


ANUH PHARMA related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about ANUH PHARMA


Is ANUH PHARMA good for long term investment?

As on Apr 16,2024, the Fundamentals of ANUH PHARMA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of ANUH PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ANUH PHARMA UnderValued or OverValued?

As on Apr 16,2024, ANUH PHARMA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of ANUH PHARMA ?

As on Apr 16,2024, the Intrinsic Value of ANUH PHARMA is Rs. 170.63 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 128.72
Fair Value [Median EV / Sales Model] : Rs. 170.63
Fair Value [Median Price / Sales Model] : Rs. 172.21
Estimated Median Fair Value of ANUH PHARMA : Rs. 170.63

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is ANUH PHARMA trading at a Premium or Discount?

As on Apr 16,2024, ANUH PHARMA is trading at a Premium of 41% based on the estimates of Median Intrinsic Value!